Sanofi-Aventis To Pay $548M For Acambis
Make a commentBy Ed Silverman // July 25th, 2008 // 2:52 pm
Buying the UK vaccine maker, which is already a partner with Sanofi on several efforts, is a “logical step”, Wayne Pisano, who heads the drugmaker’s vaccine group, Sanofi Pasteur, says in a statement. By purchasing Acambis, Sanofi gains a smallpox vaccine that was contracted by the US government for $425 million.
Sanofi is the world’s biggest maker of influenza vaccines and last month announced plans to open a $157 million plant in France, citing projections that demand for immunizations will double by 2016.
Leave a Comment
Subscribe
Comments feed for this post only.
Tags
Acambis, Sanofi Aventis, Sanofi Pasteur, Smallpox, Vaccines